Advertisement

Topics

Dr Reddy's receives FDA 483 at Indian API plant

07:15 EDT 19 Mar 2018 | in-PharmaTechnologis

The US FDA has issued a Form 483 with four observations to an API facility in Hyderabad, India run by Dr Reddyâs Laboratories.

Original Article: Dr Reddy's receives FDA 483 at Indian API plant

NEXT ARTICLE

More From BioPortfolio on "Dr Reddy's receives FDA 483 at Indian API plant"

Advertisement
Quick Search
Advertisement
Advertisement